PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 4754146

  • 1. Linear growth rate, bone maturation and growth hormone secretion in prepubertal children with congenital adrenal hyperplasia.
    Rappaport R, Bouthreuil E, Marti-Henneberg C, Basmaciogullari A.
    Acta Paediatr Scand; 1973 Sep; 62(5):513-9. PubMed ID: 4754146
    [No Abstract] [Full Text] [Related]

  • 2. [A clinical study of congenital adrenal hyperplasia].
    Nanbu A, Kumamoto Y, Tachiki H, Itoh N, Mikuma N, Tsunekawa T, Takagi Y, Maruta H.
    Hinyokika Kiyo; 1989 Nov; 35(11):1831-7. PubMed ID: 2559616
    [Abstract] [Full Text] [Related]

  • 3. Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
    Bailey CC, Komrower GM.
    Arch Dis Child; 1974 Jan; 49(1):4-7. PubMed ID: 4361889
    [No Abstract] [Full Text] [Related]

  • 4. Statural growth in congenital adrenal hyperplasia treated with hydrocortisone.
    Rappaport R, Cornu G, Royer P.
    J Pediatr; 1968 Nov; 73(5):760-6. PubMed ID: 5681168
    [No Abstract] [Full Text] [Related]

  • 5. [Hydrocortisone therapy of the AGS (adrenogenital syndrome)].
    Rager K, Huenges R, Bierich JR, Gupta D.
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):411-2. PubMed ID: 4751478
    [No Abstract] [Full Text] [Related]

  • 6. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.
    Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1114-20. PubMed ID: 10720048
    [Abstract] [Full Text] [Related]

  • 7. [Somatic development in a group of 59 children with congenital adrenal hyperplasia in relation to therapy].
    Lisá L.
    Cesk Pediatr; 1989 Dec; 44(12):712-3. PubMed ID: 2636554
    [Abstract] [Full Text] [Related]

  • 8. Experience with long-term therapy in congenital adrenal hyperplasia.
    Brook CG, Zachmann M, Prader A, Mürset G.
    J Pediatr; 1974 Jul; 85(1):12-9. PubMed ID: 4851964
    [No Abstract] [Full Text] [Related]

  • 9. Compensatory maturational deceleration of growth or "catch-down growth" in patients with congenital adrenal hyperplasia after delayed initiation of therapy.
    Hunziker U, Largo R, Zachmann M, Prader A.
    Eur J Pediatr; 1986 Apr; 144(6):550-3. PubMed ID: 3486767
    [Abstract] [Full Text] [Related]

  • 10. A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.
    Laue L, Merke DP, Jones JV, Barnes KM, Hill S, Cutler GB.
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3535-9. PubMed ID: 8855797
    [Abstract] [Full Text] [Related]

  • 11. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H, Sempé M, Morel Y, Forest MG, de Peretti E, David M.
    Arch Fr Pediatr; 1985 Oct; 42(7):511-6. PubMed ID: 2935112
    [Abstract] [Full Text] [Related]

  • 12. [Cortisol regulation in childhood hypoglycemia with adrenal medulla dysfunction].
    Tietze HU, Zurbrugg R, Zuppinger K, Joss E, Käser H.
    Schweiz Med Wochenschr; 1970 Mar 21; 100(12):545-7. PubMed ID: 5417344
    [No Abstract] [Full Text] [Related]

  • 13. The comparative effect of 6 alpha-fluoroprednisolone, 6 alpha-methylprednisolone, and hydrocortisone on linear growth of children with congenital adrenal virilism and Addison's disease.
    Laron Z, Pertzelan A.
    J Pediatr; 1968 Nov 21; 73(5):774-82. PubMed ID: 4300675
    [No Abstract] [Full Text] [Related]

  • 14. Insulin secretion in children with adrenogenital syndrome treated with low doses of oral hydrocortisone.
    Rappaport R, Auzoux M.
    Isr J Med Sci; 1972 Jun 21; 8(6):843-4. PubMed ID: 4340667
    [No Abstract] [Full Text] [Related]

  • 15. The response of pituitary gonadotropes to synthetic LRF in children with glucocorticoid-treated congenital adrenal hyperplasia: lack of effect of intrauterine and neonatal androgen excess.
    Reiter EO, Grumbach MM, Kaplan SL, Conte FA.
    J Clin Endocrinol Metab; 1975 Feb 21; 40(2):318-25. PubMed ID: 1090842
    [Abstract] [Full Text] [Related]

  • 16. Congenital adrenal hyperplasia.
    Newns GH.
    Arch Dis Child; 1974 Jan 21; 49(1):1-3. PubMed ID: 4361888
    [No Abstract] [Full Text] [Related]

  • 17. Impact of availability of oral hydrocortisone on growth of children with CAH.
    Khadilkar VV, Khadilkar AV, Maskati GB.
    Indian J Pediatr; 2005 Apr 21; 72(4):301-3. PubMed ID: 15876756
    [Abstract] [Full Text] [Related]

  • 18. Adrenal insufficiency in two male infants.
    Rossiter MA, Eades SM, Brimblecombe FS.
    Proc R Soc Med; 1970 May 21; 63(5):488-9. PubMed ID: 4318214
    [No Abstract] [Full Text] [Related]

  • 19. Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia.
    Ciaccio M, Montiveros C, Rivarola MA, Belgorosky A.
    Medicina (B Aires); 2002 May 21; 62(6):551-4. PubMed ID: 12532689
    [Abstract] [Full Text] [Related]

  • 20. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
    Rasat R, Espiner EA, Abbott GD.
    N Z Med J; 1995 Aug 11; 108(1005):311-4. PubMed ID: 7644165
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.